A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 3, 1998, Pages 547-565

  Wallis, Cleatus J ^a   Lal, Harbans ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

1 (3 chlorophenyl) piperazine (mCPP); 1 naphthyl piperazine (1 NP); 2,5 dimethoxy 4 iodoamphetamine (DOI); 5 hydroxy tryptamine (SHT); Anxiety; Benzodiazepine; Diazepam; Discrimination learning; Elevated plus maze; Gamma aminobutyric acid (GABA); Methysergide; N (3 trifluomethylphenyl) piperazine (TFMPP).; Pentylenetetrazol (PTZ); Rats; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; PENTETRAZOLE; SEROTONIN 1 RECEPTOR; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; DATA ANALYSIS; DISCRIMINATIVE STIMULUS; DRUG POTENCY; LEARNING; NONHUMAN; TRANQUILIZING ACTIVITY;

EID: 0032055361     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(98)00024-4     Document Type: Article

References (38)

1. AULAKH, C. S., HILL, J. L., and MURPHY, D. L. (1989) A comparison of feeding and locomotion responses to serotonin agonist in three rat strains. Pharmacol. Biochem. Behav. 31: 567-571.
2. 1B Characterizing agents in the mouse elevated plus-maze. Life Sci. 47: 195-203.
3. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP), Eur. J. Pharmacol. 257: 27-38.
4. CARLI, M. and SAMANIN, R. (1992) Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task. Psychopharmacol. 106: 228-234.
5. CHARNEY, D., WOODS, S., GOODMAN, W., and HENINGER, G. (1987) Serotonin function in anxiety:II. Effects of the serotonin agonist mCPP in panic disorder patients and healthy subjects. Psychopharmacol. 92: 14-21.
6. 1C receptors. TIPS 11: 181-182
7. EMMETT-OGLESBY, M. W., HARRIS, C. M., LANE, J., and LAL, H. (1984) Withdrawal from morphine generalizes to a pentylenetetrazol stimulus. Neuropeptides 5: 37-40.
8. EMMETT-OGLESBY, M. W. and HERZ, A. (1987) Opioid modulation of the discriminative stimulus produced by pentylenetetrazol. Psychopharmacol. 92: 313-319.
9. EMMETT-OGLESBY, M. W., MATHIS, D. A., HARRIS, C. M., IDEMUDIA, S. L., and LAL, H. (1988) Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol. J. Pharmacol. Exp. Ther. 244: 892-897.
10. EMMETT-OGLESBY, M. W., SPENCER, D. G., Jr., and ARNOULT, D. E. (1982) A TRS-80-based system for the control of behavioral experiments. Pharmacol. Biochem. Behav. 17: 583-587.
11. EXTANCE, K. and GOUDIE, A. J. (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacol. 73: 363-371.
12. 2 serotonin receptors: evidence for a lack of selectivity. J. Med. Chem. 35: 734-743
13. 2 binding characteristics of some quipazine analogues. J. Med. Chem. 29: 2375-2380.
14. GRAEFF, F. G. (1993) Role of 5-HT in defensive behavior and anxiety. [Review]. Reviews in the Neurosciences 4: 181-211.
15. 2A receptors expressed in fibroblasts. J. Pharmacol. Exp. Ther. 271: 1122-1126.
16. HANDLEY, S. L., MCBLANE, J. W., CRITCHLEY, M. A., and NJUNG'E, K. (1993) Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors. [Review]. Behavioural Brain Research 58: 203-210.
17. HARRIS, C. M., BENJAMIN, D., and LAL, H. (1987) Anxiety-like subjective effect of ethanol antagonist Ro 14-4513 demonstrated in pentylenetetrazol discrimination. Neuropharmacol. 26: 1545-1547.
18. HARRIS, C. M., EMMETT-OGLESBY, M. W., ROBINSON, M. W., and LAL, H. (1986) Withdrawal from chronic nicotine substitutes partially for the interoceptive stimulus produced by pentylenetetrazol (PTZ). Psychopharmacol. 93: 435-436
19. 3 receptor antagonists. Psychopharmacol. 104: 545-551.
20. 1C receptor antagonists. Eur. J. Pharmacol. 164: 445-454.
21. 1C receptor antagonists. Eur. J. Pharmacol. 164: 445-454.
22. LAL, H. and EMMETT-OGLESBY, M. W. (1983) Behavioral analogues of anxiety: animal models. Neuropharmacol. 22: 1423-1441.
23. LAL, H., HARRIS, C. M., BENJAMIN, D., SPRINGFIELD, A. C., BHADRA, S., and EMMETT-OGLESBY, M. W. (1988) Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. J. Pharmacol. Exp. Ther. 247: 508-518.
24. LAL, H., PRATHER, P. L., and REZAZADEH, S. M. (1991) Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: Reversal by buspirone. Alcohol 8: 467-471.
25. 1B receptors. [Review]. Annals New York Academy of Sciences 600: 132-147.
26. MURPHY, D. L., MUELLER, E. A., HILL, J. L., TOLLIVER, T. J., and JACOBSEN, F. M. (1989) Comparative anxiogenic, neuroendocrine, and other physiological effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers. Psychopharmacol. 98: 275-282.
27. PRATHER, P. L., REZAZADEH, S. M., LANE, J. D., ROWAN, G. A., HOOPER, M. L., LYTLE, D. A., EMMETT-OGLESBY, M. W., and LAL, H. (1993) Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal. J. Pharmacol. Exp. Ther. 264: 622-630.
28. 1C receptor agonist in rats observed following withdrawal from chronic ethanol. Alcohol 10: 281-283.
29. 2 receptors: implications for treating LSD-induced hallucinogenesis. Psychopharmacol. 98: 495-499.
30. SANGER, D. J., PERRAULT, G., MOREL, E., JOLY, D., and ZIVKOVIC, B. (1991) Animal models of anxiety and the development of novel anxiolytic drugs. Prog. Neuropsychopharmacol. Biol. Psychiat. 15: 205-212.
31. SEIBYL, J. P., KRYSTAL, J. H., PRICE, L. H., WOODS, S. W., D'AMICO, C., HENINGER, G. R., and CHARNEY, D. S. (1991) Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Psychiatry Research 38: 227-236.
32. SPENCER, D. G. and EMMETT-OGLESBY, M. W. (1985) Parallel processing strategies in the application of microcomputers to the behavioral laboratory. Behav. Res. Methods Instr. Comp. 17: 294-300.
33. 2 receptor subtypes. Mol. Pharmacol. 38: 594-598.
34. 2 receptors as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacol. 94: 213-216.
35. WALLIS, C. J., REZAZADEH, S. M., and LAL, H. (1993) Role of serotonin in ethanol abuse. Drug Dev. Res. 30: 178-188.
36. WILSON, D. E. and BENNETT, D. A. (1989) Pentylenetetrazol discriminative stimuli are selective for identifying benzodiazepine receptor modulating agents. Drug Dev. Res. 17:237-244.
37. WOOD, D. M., LARABY, P. R., and LAL, H. (1989) A pentylenetetrazol-like stimulus during cocaine withdrawal: blockade by diazepam but not haloperidol. Drug Dev. Res. 16: 269-276.
38. ZUARDI, A. W. (1990) 5-HT-related drugs and human experimental anxiety. Neurosci. Biobehav. Rev. 14: 507-510.